معرفی
Dr. D. (Danny) Wilbie serves as a Lecturer and Researcher in the Department of Pharmaceutics within the Faculty of Science at Utrecht University. His academic work focuses on advanced drug delivery systems with particular emphasis on gene editing technologies and pharmaceutical formulations.
Wilbie's research interests span protein formulation, biopharmaceutics, cell biology, and CRISPR-based gene editing technologies. His work bridges pharmaceutical sciences with cutting-edge molecular biology techniques, developing novel delivery systems for therapeutic applications. Key areas include lipid nanoparticles for CRISPR delivery, thermosensitive hydrogels for ocular therapy, and nanocluster-based theranostic systems.
His publication record demonstrates a strong focus on gene editing delivery systems, with his 2019 review in Accounts of Chemical Research becoming highly influential (231 citations). Recent work shows progression toward practical applications of CRISPR technology, including methods for screening editing outcomes and improving DNA repair mechanisms for therapeutic correction.
Wilbie maintains active collaborations with researchers including Mastrobattista, Walther, and Vermonden, indicating established research networks within Utrecht University's pharmaceutical sciences community. His work has generated significant academic attention, with multiple publications receiving over 50 Mendeley readers and some being referenced in patents.
